Reported Standalone quarterly numbers for Panacea Biotec are:Net Sales at Rs 75.02 crore in March 2023 up 80.77% from Rs. 41.50 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 19.69 crore in March 2023 up 22.2% from Rs. 25.31 crore in March 2022.
EBITDA stands at Rs. 13.70 crore in March 2023 up 181.5% from Rs. 16.81 crore in March 2022.
Panacea Biotec shares closed at 122.40 on May 29, 2023 (NSE) and has given -12.60% returns over the last 6 months and -14.82% over the last 12 months.
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 75.02 | 71.97 | 41.50 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 75.02 | 71.97 | 41.50 | | EXPENDITURE | | Consumption of Raw Materials | 36.16 | 28.50 | 23.73 | | Purchase of Traded Goods | 0.75 | -- | -- | | Increase/Decrease in Stocks | -6.00 | -0.23 | -10.80 | | Power & Fuel | -- | -- | -- | | Employees Cost | 19.03 | 17.49 | 18.55 | | Depreciation | 5.90 | 6.08 | 7.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 21.65 | 13.92 | 29.40 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.47 | 6.21 | -26.44 | | Other Income | 10.27 | 9.71 | 2.57 | | P/L Before Int., Excpt. Items & Tax | 7.80 | 15.92 | -23.87 | | Interest | 2.70 | 2.68 | 1.44 | | P/L Before Exceptional Items & Tax | 5.10 | 13.24 | -25.31 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 5.10 | 13.24 | -25.31 | | Tax | 24.79 | -- | -- | | P/L After Tax from Ordinary Activities | -19.69 | 13.24 | -25.31 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -19.69 | 13.24 | -25.31 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.21 | 2.16 | -4.13 | | Diluted EPS | -3.21 | 2.16 | -4.13 | | EPS After Extra Ordinary | | Basic EPS | -3.21 | 2.16 | -4.13 | | Diluted EPS | -3.21 | 2.16 | -4.13 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
